Regulatory mechanisms of inflammation in epithelial mesenchymal transition

doi:10.3760/cma.j.issn.1673-422X.2014.02.004

Abstract

Abstract: Inflammation plays an important role in the initiation and development of tumor. Epithelialmesenchymal transition (EMT) acts as a critical molecular mechanism involved in the proliferation, invasion and metastasis of tumor. Mounting studies show that inflammation is related with EMT closely. In the inflammatory microenvironment, both cytokines and microbes take part in the regulation of EMT.

Key words: Inflammation, Neoplasm invasiveness, Neoplasm metastasis, Epithelial mesenchymal transition

Shan Zezhi, Yan Xuebing, Jin Zhiming. Regulatory mechanisms of inflammation in epithelial mesenchymal transition[J]. Journal of International Oncology, 2014, 41(2): 90-93.

References

［1］ Herrinton LJ, Liu L, Levin TR, et al. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010［J］. Gastroenterology, 2012, 143(2): 382-389. ［2］ Raimondi S, Lowenfels AB, MorselliLabate AM, et al. Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection［J］. Best Pract Res Clin Gastroenterol, 2010, 24(3): 349-358. ［3］ Brenner DR, Boffetta P, Duell EJ, et al. Previous lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer Consortium［J］. Am J Epidemiol, 2012, 176(7): 573-585. ［4］ Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer［J］. Cell, 2010, 140(6): 883-899. ［5］ Wang Y, Shang Y. Epigenetic control of epithelialtomesenchymal transition and cancer metastasis［J］. Exp Cell Res, 2013, 319(2): 160-169. ［6］ Meng F, Wu G. The rejuvenated scenario of epithelialmesenchymal transition (EMT) and cancer metastasis［J］. Cancer Metastasis Rev, 2012, 31(34): 455-467. ［7］ Vrba L, Jensen TJ, Garbe JC, et al. Role for DNA methylation in the regulation of miR200c and miR141 expression in normal and cancer cells［J］. PLoS One, 2010, 5(1): e8697. ［8］ Kaimori A, Potter JJ, Choti M, et al. Histone deacetylase inhibition suppresses the transforming growth factor beta1induced epithelialtomesenchymal transition in hepatocytes［J］. Hepatology, 2010, 52(3): 1033-1045. ［9］ Levy L, Hill CS. Alterations in components of the TGFbeta superfamily signaling pathways in human cancer［J］. Cytokine Growth Factor Rev, 2006, 17(12): 41-58. ［10］ vThiery JP, Acloque H, Huang RY, et al. Epithelialmesenchymal transitions in development and disease［J］. Cell, 2009, 139(5): 871-890. ［11］ Derynck R, Zhang YE. Smaddependent and Smadindependent pathways in TGFbeta family signalling［J］. Nature, 2003, 425(6958): 577584. ［12］ Miyazono K, Ehata S, Koinuma D. Tumorpromoting functions of transforming growth factorβ in progression of cancer［J］. Ups J Med Sci, 2012, 117(2): 143152. ［13］ Morrison CD, Parvani JG, Schiemann WP. The relevance of the TGFβ Paradox to EMTMET programs［J］. Cancer Lett, 2013, 341(1): 3040. ［14］ Wang H, Wang HS, Zhou BH, et al. Epithelialmesenchymal transition (EMT) Induced by TNFα requires AKT/GSK 3β mediated stabilization of snail in colorectal cancer［J］. PLoS One, 2013, 8(2): e56664. ［15］ Wang H, Fang R, Wang XF, et al. Stabilization of Snail through AKT/GSK3β signaling pathway is required for TNFαinduced epithelialmesenchymal transition in prostate cancer PC3 cells［J］. Eur J Pharmacol, 2013, 714(13): 48-55. ［16］ Maier HJ, SchmidtStrassburger U, Huber MA, et al. NFkappaB promotes epithelialmesenchymal transition, migration and invasion of pancreatic carcinoma cells［J］. Cancer Lett, 2010, 295(2): 214-228. ［17］ Tang FY, Pai MH, Chiang EP. Consumption of highfat diet induces tumor progression and epithelialmesenchymal transition of colorectal cancer in a mouse xenograft model［J］. J Nutr Biochem, 2012, 23(10): 1302-1313. ［18］ Zhao Y, Xu Y, Li Y, et al. NFκBmediated inflammation leading to EMT via miR200c is involved in cell transformation induced by cigarette smoke extract［J］. Toxicol Sci, 2013, 135(2): 265-276. ［19］ Chen MF, Lin PY, Wu CF, et al. IL6 expression regulates tumorigenicity and correlates with prognosis in bladder cancer［J］. PLoS One, 2013, 8(4): e61901. ［20］ Li XJ, Peng LX, Shao JY, et al. As an independent unfavorable prognostic factor, IL8 promotes metastasis of nasopharyngeal carcinoma through induction of epithelialmesenchymal transition and activation of AKT signaling［J］. Carcinogenesis, 2012, 33(7): 1302-1309. ［21］ Fernando RI, Castillo MD, Litzinger M, et al. IL8 signaling plays a critical role in the epithelialmesenchymal transition of human carcinoma cells［J］. Cancer Res, 2011, 71(15): 5296-5306. ［22］ GironMichel J, Azzi S, Ferrini S, et al. Interleukin15 is a major regulator of the cellmicroenvironment interactions in human renal homeostasis［J］. Cytokine Growth Factor Rev, 2013, 24(1): 13-22. ［23］ Li Y, Wang L, Pappan L, et al. IL1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation［J］. Mol Cancer, 2012, 11: 87. ［24］ Yin Y, Grabowska AM, Clarke PA, et al. Helicobacter pylori potentiates epithelial: mesenchymal transition in gastric cancer: links to soluble HBEGF, gastrin and matrix metalloproteinase7［J］. Gut, 2010, 59(8): 1037-1045. ［25］ Yang SZ, Zhang LD, Zhang Y, et al. HBx protein induces EMT through cSrc activation in SMMC7721 hepatoma cell line［J］. Biochem Biophys Res Commun, 2009, 382(3): 555-560. ［26］ Battaglia S, Benzoubir N, Nobilet S, et al. Liver cancerderived hepatitis C virus core proteins shift TGFbeta responses from tumor suppression to epithelialmesenchymal transition［J］. PLoS One, 2009, 4(2): e4355.

[1]	Wang Ying, Liu Nan, Guo Bing. Advances of antibody-drug conjugate in the therapy of metastatic breast cancer [J]. Journal of International Oncology, 2024, 51(6): 364-369.
[2]	Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing. Progress of radiotherapy in oligometastatic non-small cell lung cancer [J]. Journal of International Oncology, 2024, 51(3): 170-174.
[3]	Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan. Research progress on the histopathological growth patterns of colorectal liver metastasis [J]. Journal of International Oncology, 2024, 51(2): 114-118.
[4]	Zhang Lu, Jiang Hua, Lin Zhou, Ma Chenying, Xu Xiaoting, Wang Lili, Zhou Juying. Analysis of curative effect and prognosis of immune checkpoint inhibitor in the treatment of recurrent and metastatic cervical cancer [J]. Journal of International Oncology, 2023, 50(8): 475-483.
[5]	He Guangsi, Wang Jun, Feng Mengmeng. Predictive value of inflammatory markers of peripheral blood cells on prognosis in the advanced non-small cell lung cancer with immune therapy [J]. Journal of International Oncology, 2023, 50(6): 321-327.
[6]	Yang Lirong, Wang Yufeng. Construction of machine learning models for predicting the risk of postoperative distant metastasis recurrence in serous ovarian cancer [J]. Journal of International Oncology, 2023, 50(4): 220-226.
[7]	Huang Zhen, Zhang Caiyutian, Ke Shaobo, Shi Wei, Zhao Wensi, Chen Yongshun. Construction of postoperative prognosis model for patients with colorectal cancer [J]. Journal of International Oncology, 2023, 50(3): 157-163.
[8]	Ma Peihan, Zhang Lingming, Lu Ning, Zhang Mingxin. Effect of anesthesia on the recurrence and metastasis of hepatocellular carcinoma [J]. Journal of International Oncology, 2023, 50(2): 117-121.
[9]	Zhao Jianhao, Duan Yanchao. Research progress in the pathogenesis of extramedullary disease in multiple myeloma [J]. Journal of International Oncology, 2023, 50(1): 55-59.
[10]	Zhang Lu, Zhou Juying, Ma Chenying, Lin Zhou. Advances in immunotherapy for recurrent and metastatic cervical cancer [J]. Journal of International Oncology, 2022, 49(9): 517-520.
[11]	Peng Chen, Xie Yintong, Zhang Xin, Xie Peng. Research progress of maintenance therapy for cervical cancer [J]. Journal of International Oncology, 2022, 49(7): 430-435.
[12]	Liu Yonghong, Xue Lingbo, Bai Yang, Jin Jian, Zang Chunxia, Zhang Bo, Li Jie. Predictive value of systemic inflammation response index before treatment for pathological complete response in patients with breast cancer undergoing neoadjuvant chemotherapy [J]. Journal of International Oncology, 2022, 49(4): 210-215.
[13]	Wang Bin, Zhou Jiangyun, Liu Xi. Analysis of the clinical value of different radiotherapy schemes in patients with advanced esophageal squamous cell carcinoma [J]. Journal of International Oncology, 2021, 48(8): 484-488.
[14]	Jiang Mengting, Wang Jiachun, Zong Jing. Effects of NFAT5 inhibition on proliferation, invasion, migration and apoptosis of lung adenocarcinoma cells [J]. Journal of International Oncology, 2021, 48(6): 321-327.
[15]	Wang Ziyi, Chen Hongjie, Yang Ninggang, Zhang Jun, Zhang Xiangjun, Yu Xinning, Ma Zhongyi, Dai Enlai. Effects of decorin on proliferation, migration and invasion of bladder cancer cells [J]. Journal of International Oncology, 2021, 48(6): 335-340.